AC8 0.00% 4.0¢ auscann group holdings ltd

Ann: AusCann Releases Hard-shell Capsules to Clinical Evaluation, page-24

  1. 44,861 Posts.
    lightbulb Created with Sketch. 642
    didn't you read the Ann. SH? A few MONTHS for caps to be assessed... then comes the marketing for caps to be filled with a range of prescription meds. We are perhaps 6 to 12 months from revenue.
 
watchlist Created with Sketch. Add AC8 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.